Review



cyclin d  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Boster Bio cyclin d
    Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and <t>cyclin</t> <t>D</t> in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA
    Cyclin D, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 292 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/Anti-PCNA+Antibody/pmc12819934-58-34-38
    Average 95 stars, based on 292 article reviews
    cyclin d - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate"

    Article Title: Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate

    Journal: Cellular and Molecular Life Sciences: CMLS

    doi: 10.1007/s00018-025-06071-3

    Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and cyclin D in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA
    Figure Legend Snippet: Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and cyclin D in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA

    Techniques Used: Western Blot, Knockdown, Negative Control

    Related Articles

    Incubation:

    Article Title: Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate
    Article Snippet: .. The antibody against CEBPB (PB9171, BA0670, 1:500, Boster, Wuhan, China), H3K27ac (A7253, 1:500, ABclonal, Wuhan, China), H3K4me1 (A2355, 1:500, Wuhan, China), PCNA (A00125, 1:500, Boster, Wuhan, China), Cyclin A (PB0515, 1:500, Boster, Wuhan, China), Cyclin D (BM4272, 1:500, Boster, Wuhan, China), IL-6 (AF7236, 1:500, Beyotime, Shanghai, China), TNF-α (AF8208, 1:500, Beyotime, Shanghai, China), PKM2 (4053, 1:1000, Cell Signaling, MA, US), HK II (66974-1-Ig, 1:1000, Proteintech, IL, USA), PDH (2784, 1:1000, Cell Signaling, MA, US), HSPA9 (14887-1-AP, 1:5000, Proteintech, IL, USA), VDAC1 (10866-1-AP, 1:5000, Proteintech, IL, USA), and β-actin (TA-09, 1:1000, ZSGB‐BIO, Beijing, China) was incubated at 4 °C overnight, followed by incubation with appropriate horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h, and proteins were visualized with enhanced chemiluminescence reagents. .. The total RNA of tissue or PASMCs samples was extracted by TRIzol reagent (Thermo Fisher, MA) according to the manufacturer’s protocol.

    Article Title: Downregulation of long non‑coding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells.
    Article Snippet: .. These membranes were blocked at room temperature for 1 h in blocking buffer (Tris 20 mM, pH 7.6, nacl 150 mM and Tween 20 0.1%) containing 5% nonfat dry milk and incubated with Pcna (Boster Biological Technology; cat. no. BM3888; anti-Pcna antibody; 1:400), cyclin a (Boster Biological Technology; cat. no. BM4673; anti-cyclin a2 antibody; 1:200), cyclin d (Boster Biological Technology; cat. no. BM4272; anti-cyclin d1 antibody; 1:200), cyclin e (Boster Biological Technology; cat. no. BM4658; anti-cyclin e2 antibody; 1:100), β-actin (Boster Biological Technology; cat. no. BM0627; anti-β-actin antibody; 1:2,000) at 4̊C overnight. .. Secondary antibodies [Beyotime institute of Biotechnology; cat. no. a0208; horseradish peroxidase (HrP)-labeled Goat anti-rabbit igG(H+l); 1:10,000; cat. no. a0216; HrP-labeled Goat anti-Mouse igG(H+l); 1:12,000] were prepared according to the corresponding proportion and species, and incubated at room temperature for 1 h. The proteins were visualized with enhanced chemiluminescence reagents (Super Signal; Pierce; Thermo Fisher Scientific, Inc.).

    Article Title: Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation.
    Article Snippet: pulmonary artery smooth muscle cell proliferation Hongyue Zhang, Ying Liu, Lixin Yan, Siqi Wang, Min Zhang, Cui Ma, Xiaodong Zheng, He Chen and Daling Zhu 1, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China; 2, Central Laboratory of Harbin Medical University-Daqing, Daqing, Heilongjiang, China; 3, College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, China.. 4, College of Medical Laboratory Science and Technology, Harbin Medical UniversityDaqing, Daqing, Heilongjiang, China; 5, Department of Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China; 6, Department of Obstetrics and gynecology, The Second affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.. Correspondence and requests for reprints should be addressed to Daling Zhu Department of Biopharmaceutical Sciences, Harbin Medical University (Daqing), Xinyang Road, Daqing, Heilongjiang 163319, China.

    Article Title: Fibroblast growth factor 21 (FGF21) promotes porcine granulosa cell estradiol production and proliferation via PI3K/AKT/mTOR signaling.
    Article Snippet: The proliferation and steroidogenesis of mammalian ovarian granulosa cells (GCs) are related to follicular development.. Previous studies found that fibroblast growth factor 21 (FGF21) regulated female fertility through the hypothalamicepituitaryegonad axis.. However, FGF21 receptors are expressed on GCs, so we speculate that it might affect female reproduction by regulating their physiological activities.

    Blocking Assay:

    Article Title: Downregulation of long non‑coding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells.
    Article Snippet: .. These membranes were blocked at room temperature for 1 h in blocking buffer (Tris 20 mM, pH 7.6, nacl 150 mM and Tween 20 0.1%) containing 5% nonfat dry milk and incubated with Pcna (Boster Biological Technology; cat. no. BM3888; anti-Pcna antibody; 1:400), cyclin a (Boster Biological Technology; cat. no. BM4673; anti-cyclin a2 antibody; 1:200), cyclin d (Boster Biological Technology; cat. no. BM4272; anti-cyclin d1 antibody; 1:200), cyclin e (Boster Biological Technology; cat. no. BM4658; anti-cyclin e2 antibody; 1:100), β-actin (Boster Biological Technology; cat. no. BM0627; anti-β-actin antibody; 1:2,000) at 4̊C overnight. .. Secondary antibodies [Beyotime institute of Biotechnology; cat. no. a0208; horseradish peroxidase (HrP)-labeled Goat anti-rabbit igG(H+l); 1:10,000; cat. no. a0216; HrP-labeled Goat anti-Mouse igG(H+l); 1:12,000] were prepared according to the corresponding proportion and species, and incubated at room temperature for 1 h. The proteins were visualized with enhanced chemiluminescence reagents (Super Signal; Pierce; Thermo Fisher Scientific, Inc.).

    Article Title: Long noncoding RNA Hoxaas3 contributes to hypoxia-induced pulmonary artery smooth muscle cell proliferation.
    Article Snippet: pulmonary artery smooth muscle cell proliferation Hongyue Zhang, Ying Liu, Lixin Yan, Siqi Wang, Min Zhang, Cui Ma, Xiaodong Zheng, He Chen and Daling Zhu 1, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China; 2, Central Laboratory of Harbin Medical University-Daqing, Daqing, Heilongjiang, China; 3, College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang, China.. 4, College of Medical Laboratory Science and Technology, Harbin Medical UniversityDaqing, Daqing, Heilongjiang, China; 5, Department of Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China; 6, Department of Obstetrics and gynecology, The Second affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.. Correspondence and requests for reprints should be addressed to Daling Zhu Department of Biopharmaceutical Sciences, Harbin Medical University (Daqing), Xinyang Road, Daqing, Heilongjiang 163319, China.

    other:

    Article Title: Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation
    Article Snippet: Antibodies against Cyclin A, Cyclin D, PCNA, UB, P62, ATG5 and ATG7 (Catalog numbers BM1582, BM4272, BM0104, BM4359, BA2849, BA3525 and BA3527) were obtained from Boster (Wuhan, China).



    Similar Products

    86
    G1 Therapeutics heteroaryl pyrrolo 3 2 d pyrimidin 2 amine cyclin dependent kinase inhibitors
    Heteroaryl Pyrrolo 3 2 D Pyrimidin 2 Amine Cyclin Dependent Kinase Inhibitors, supplied by G1 Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/2+2+3+amine+cyclin+d+dependent+heteroaryl+inhibitors+kinase+n+pyrimidin+pyrrolo/us12565502-938-25-19
    Average 86 stars, based on 1 article reviews
    heteroaryl pyrrolo 3 2 d pyrimidin 2 amine cyclin dependent kinase inhibitors - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology d 7 catalog sc 6283
    D 7 Catalog Sc 6283, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/cyclin+D3+Antibody/pm41708853-923-130-139
    Average 95 stars, based on 1 article reviews
    d 7 catalog sc 6283 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Santa Cruz Biotechnology d 7
    D 7, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/cyclin+D3+Antibody/pm41708853-511-78-86
    Average 95 stars, based on 1 article reviews
    d 7 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    86
    Absolute Biotech Inc cyclin d
    Inhibition of FOSL1 in GBM cells reverses TMZ response. (A, B) Representative histogram of protein expression, including FOSL1 and cell cycle‐associated molecules, in GBM patient's cells was shown (top panel). Protein expression in patients with GBM‐derived cells ( n = 6), including FOSL1 and cell cycle‐associated molecules, was analyzed by flow cytometry and quantified using FlowJo V10 (bottom panel). (C) FOSL1 mRNA expression (left panel) in U87MG treated with si‐control or si‐FOSL1 analyzed using qPCR. GAPDH was used as a control gene for relative quantification. FOSL1 protein expression in U87MG treated with si‐control or si‐FOSL1 was analyzed by flow cytometry and quantified using FlowJo V10 (right panel). (D) Expression of G0/G1 to S phase transition‐related proteins, including CDK4, cyclin D, CDK2, and cyclin E, analyzed using flow cytometry and quantified using FlowJo V10. E Population of the G0/G1 phase of U87MG cells stained with CCS1 and analyzed using flow cytometry. Data were quantified using FlowJo V10. (F) Representative images of colony formation showing viable U87MG cells treated with si‐control, si‐FOSL1 or TMZ (purple). (G) Proliferation of U87MG cells calculated using the WST‐8 reduction assay following the manufacturer's instructions. *p < 0.05; **p < 0.005; ***p < 0.0005; paired t ‐test ( n = 3).
    Cyclin D, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/anti+cyclin+d/pmc12812332-175-56-59
    Average 86 stars, based on 1 article reviews
    cyclin d - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc cyclin d 3
    Inhibition of FOSL1 in GBM cells reverses TMZ response. (A, B) Representative histogram of protein expression, including FOSL1 and cell cycle‐associated molecules, in GBM patient's cells was shown (top panel). Protein expression in patients with GBM‐derived cells ( n = 6), including FOSL1 and cell cycle‐associated molecules, was analyzed by flow cytometry and quantified using FlowJo V10 (bottom panel). (C) FOSL1 mRNA expression (left panel) in U87MG treated with si‐control or si‐FOSL1 analyzed using qPCR. GAPDH was used as a control gene for relative quantification. FOSL1 protein expression in U87MG treated with si‐control or si‐FOSL1 was analyzed by flow cytometry and quantified using FlowJo V10 (right panel). (D) Expression of G0/G1 to S phase transition‐related proteins, including CDK4, cyclin D, CDK2, and cyclin E, analyzed using flow cytometry and quantified using FlowJo V10. E Population of the G0/G1 phase of U87MG cells stained with CCS1 and analyzed using flow cytometry. Data were quantified using FlowJo V10. (F) Representative images of colony formation showing viable U87MG cells treated with si‐control, si‐FOSL1 or TMZ (purple). (G) Proliferation of U87MG cells calculated using the WST‐8 reduction assay following the manufacturer's instructions. *p < 0.05; **p < 0.005; ***p < 0.0005; paired t ‐test ( n = 3).
    Cyclin D 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/pmc12880981-17-0-9
    Average 86 stars, based on 1 article reviews
    cyclin d 3 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    95
    Boster Bio cyclin d
    Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and <t>cyclin</t> <t>D</t> in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA
    Cyclin D, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/Anti-PCNA+Antibody/pmc12819934-58-34-38
    Average 95 stars, based on 1 article reviews
    cyclin d - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    96
    Proteintech cyclin d
    Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and <t>cyclin</t> <t>D</t> in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA
    Cyclin D, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cyclin+d/Cyclin+D1+Antibody/pm41386358-98-50-53
    Average 96 stars, based on 1 article reviews
    cyclin d - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Inhibition of FOSL1 in GBM cells reverses TMZ response. (A, B) Representative histogram of protein expression, including FOSL1 and cell cycle‐associated molecules, in GBM patient's cells was shown (top panel). Protein expression in patients with GBM‐derived cells ( n = 6), including FOSL1 and cell cycle‐associated molecules, was analyzed by flow cytometry and quantified using FlowJo V10 (bottom panel). (C) FOSL1 mRNA expression (left panel) in U87MG treated with si‐control or si‐FOSL1 analyzed using qPCR. GAPDH was used as a control gene for relative quantification. FOSL1 protein expression in U87MG treated with si‐control or si‐FOSL1 was analyzed by flow cytometry and quantified using FlowJo V10 (right panel). (D) Expression of G0/G1 to S phase transition‐related proteins, including CDK4, cyclin D, CDK2, and cyclin E, analyzed using flow cytometry and quantified using FlowJo V10. E Population of the G0/G1 phase of U87MG cells stained with CCS1 and analyzed using flow cytometry. Data were quantified using FlowJo V10. (F) Representative images of colony formation showing viable U87MG cells treated with si‐control, si‐FOSL1 or TMZ (purple). (G) Proliferation of U87MG cells calculated using the WST‐8 reduction assay following the manufacturer's instructions. *p < 0.05; **p < 0.005; ***p < 0.0005; paired t ‐test ( n = 3).

    Journal: MedComm

    Article Title: Inhibition of FOS‐Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL‐6/STAT3 Tyr705 Pathway

    doi: 10.1002/mco2.70593

    Figure Lengend Snippet: Inhibition of FOSL1 in GBM cells reverses TMZ response. (A, B) Representative histogram of protein expression, including FOSL1 and cell cycle‐associated molecules, in GBM patient's cells was shown (top panel). Protein expression in patients with GBM‐derived cells ( n = 6), including FOSL1 and cell cycle‐associated molecules, was analyzed by flow cytometry and quantified using FlowJo V10 (bottom panel). (C) FOSL1 mRNA expression (left panel) in U87MG treated with si‐control or si‐FOSL1 analyzed using qPCR. GAPDH was used as a control gene for relative quantification. FOSL1 protein expression in U87MG treated with si‐control or si‐FOSL1 was analyzed by flow cytometry and quantified using FlowJo V10 (right panel). (D) Expression of G0/G1 to S phase transition‐related proteins, including CDK4, cyclin D, CDK2, and cyclin E, analyzed using flow cytometry and quantified using FlowJo V10. E Population of the G0/G1 phase of U87MG cells stained with CCS1 and analyzed using flow cytometry. Data were quantified using FlowJo V10. (F) Representative images of colony formation showing viable U87MG cells treated with si‐control, si‐FOSL1 or TMZ (purple). (G) Proliferation of U87MG cells calculated using the WST‐8 reduction assay following the manufacturer's instructions. *p < 0.05; **p < 0.005; ***p < 0.0005; paired t ‐test ( n = 3).

    Article Snippet: For intracellular protein analysis, U87MG cells and patient‐derived GBM cells were collected and incubated in permeabilization buffer (#554722; BD Biosciences) at 4°C for 20 min. After washing with Perm/Wash Buffer, cells were stained at 4°C for 30 min using the following primary antibodies: anti‐FOSL1 (#PA5‐76185; Thermo Fisher Scientific), CDK2 (#LS‐C351983; LSBio), CDK4 (#LS‐ C99873 ; LSBio), cyclin D (#LS‐B4507; LSBio), cyclin E (#32‐1600; Thermo Fisher Scientific), Oct4 (#ab184665; Abcam), Nanog (#ab109250; Abcam), Sox2 (#ab171380; Abcam), MGMT (#MA5‐13506; Thermo Fisher Scientific), IL‐6 (#M620; Thermo Fisher Scientific), STAT3 (#710077; Thermo Fisher Scientific), phospho‐STAT3 Ser727 (#PA5‐17876; Thermo Fisher Scientific), phospho‐STAT3 Tyr705 (#MA5‐15193; Thermo Fisher Scientific), and intracellular ROS (#ab113851; Abcam).

    Techniques: Inhibition, Expressing, Derivative Assay, Flow Cytometry, Control, Quantitative Proteomics, Sublimation, Staining

    Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and cyclin D in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Super enhancer-driven LINC01013 mediates hypoxia-induced mitochondrial dysfunction by HSPA9 to determine pulmonary arterial smooth muscle cell fate

    doi: 10.1007/s00018-025-06071-3

    Figure Lengend Snippet: Silencing of LINC01013 inhibited hypoxia-induced hPASMC proliferation and inflammation. A , B hPASMC proliferation was determined by CCK8 and EdU incorporation assays ( n = 6). EdU (red), DAPI (blue), scale bar, 50 μm. C Western blotting analysis of PCNA, cyclin A and cyclin D in hPASMCs ( n = 6). D RT‒qPCR analysis showed the mRNA levels of TNF-α and IL-6 after LINC01013 knockdown, β-actin was used as a internal reference gene ( n = 6). E Western blotting analysis of TNF-α and IL-6 in hPASMCs. ( n = 6). All values are presented as the mean ± SEM. Statistical analysis was performed with one-way ANOVA. * p < 0.05, ** p < 0.01, *** p < 0.001. Nor, normoxia; Hyp, hypoxia; NC, negative control; si, siRNA

    Article Snippet: The antibody against CEBPB (PB9171, BA0670, 1:500, Boster, Wuhan, China), H3K27ac (A7253, 1:500, ABclonal, Wuhan, China), H3K4me1 (A2355, 1:500, Wuhan, China), PCNA (A00125, 1:500, Boster, Wuhan, China), Cyclin A (PB0515, 1:500, Boster, Wuhan, China), Cyclin D (BM4272, 1:500, Boster, Wuhan, China), IL-6 (AF7236, 1:500, Beyotime, Shanghai, China), TNF-α (AF8208, 1:500, Beyotime, Shanghai, China), PKM2 (4053, 1:1000, Cell Signaling, MA, US), HK II (66974-1-Ig, 1:1000, Proteintech, IL, USA), PDH (2784, 1:1000, Cell Signaling, MA, US), HSPA9 (14887-1-AP, 1:5000, Proteintech, IL, USA), VDAC1 (10866-1-AP, 1:5000, Proteintech, IL, USA), and β-actin (TA-09, 1:1000, ZSGB‐BIO, Beijing, China) was incubated at 4 °C overnight, followed by incubation with appropriate horseradish peroxidase-conjugated secondary antibodies at room temperature for 1 h, and proteins were visualized with enhanced chemiluminescence reagents.

    Techniques: Western Blot, Knockdown, Negative Control